NX
NEXGEL, Inc.
NXGLW · NASDAQ
$0.01 -96.02% (-$0.30)
1M -49.80%
Market Cap $1.14M
P/E Ratio -
Div. Yield -
ROE 133.10%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.09x
P/B 0.23x
P/E N/A
Growth
78 /100
Growing Rev. growth 77.33%
Book val. growth 16.42%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 35.07%
FCF margin 27.10%
Net margin 51.26%
Quality
6 /100
Poor ROIC 42.52%
Asset turnover 0.46x
ROE 133.10%
Debt
17 /100
High Debt/Equity 1.49x
Int. coverage -1.73x
Current ratio 0.43x
Stability
56 /100
Moderate Beta 0.77x
Profitable years 0
Rev. volatility 43.55%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NXGLW
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Adam R. Levy
Employees
19
Headquarters
Langhorne
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report